
Journal of Medicinal Chemistry p. 1704 - 1711 (1994)
Update date:2022-08-05
Topics:
Gualtieri
Conti
Dei
Giovannoni
Nannucci
Romanelli
Scapecchi
Teodori
Fanfani
Ghelardini
Giotti
Bartolini
Previous studies have shown that (R)-(+)-hyoscyamine has analgesic activity as a consequence of increased ACh release following antagonism of central muscarinic autoreceptors. Since the enhancement of central cholinergic transmission could be beneficial for cognitive disorders, we manipulated (R)-(+)-hyoscyamine, synthesizing several derivatives of tropic and 2-phenylpropionic acids, with the aim of obtaining drugs which are able to increase ACh release and consequently to show analgesic and nootropic activities. The results showed that several new compounds are indeed potent analgesics (with an analgesic efficacy comparable to that of morphine) and that the most potent one ((±)-19, PG9) also has remarkable cognition- enhancing properties. Our study confirmed that the mechanism of action involves ACh release even if it is still unclear whether only muscarinic autoreceptors or, also, heteroreceptors are involved.
View MoreContact:+1-973-357-0577
Address:10 Taft Rd.
Kaymossy BioChem Tech Co., Ltd
website:http://www.kaimosi.com
Contact:0571-87191913/0571-87199097
Address:Room 215, Building 3rd, No.288 Ningxia Road, Qingdao city, China
Nantong Kaixin Pharma Chemical Co.,Ltd.
Contact:86-513-85250786
Address:2-1103 Huachen Mansion, 111 Gongnong Road,Nantong, Jiangsu, China
Contact:0086-357-6662688
Address:Zhaocheng town, Hongtong County, Linfen City, Shanxi Province
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Doi:10.1021/jo00954a018
(1973)Doi:10.1002/jhet.5570260525
(1989)Doi:10.1016/S0040-4039(00)76681-0
(1994)Doi:10.1021/jo00951a038
(1973)Doi:10.3184/030823408X320629
(2008)Doi:10.1021/acs.jmedchem.7b01492
(2019)